General discussion, page-7348

First 7348 Last

19stevo71

1,474 Posts.

172

25/08/21

14:49

Post #: 55563015

Originally posted by Mujtabazafar: ↑
Hi TV,
Thanks for the reply. Based on the info you provided, below is my back of the envelope estimation.
Dsiclosure: I dont have a bio/med background so I might have grossly over/under estimated the potential of upcoming milestones. Please feel free to correct me and adjust the projections.

Timeline
Expected Events
Share Price Projection
1
Dec 2021
1.IHL 42X – Complete Phase 2 Trials – Submit FDA Pre-IND
2.IHL – 216A - Complete Phase 2 Trials – Submit FDA Pre-IND
3.IHL 675A – Complete Phase 1 Trials (IBD, ILD, RA)
4.PSI – GAD (Commence Phase 2A trials)

75 – 99 Cents

2
March 2022
1.IHL 675A - Submit FDA Pre-IND
$0.8 to $1.2
3
September 2022
1.IND submission for IHL 42X
2.IND submission for IHL 216A
3.Submission of FDA Pre-IND for Phase 2 trials of IHL 675 A )(IBD, ILD)
4.IND Submission for PSI – General Anxiety Disorder
$1 - $1.5
4
June 2023
1.IND submission for IHL 675 (RA)
$1.2 - $1.75
Expand
My method is much more sophisticated , I just reckon each successful trial is worth 1b and we may have 6 of them =6b target in a few years.

IHL Price at posting: 40.0¢ Sentiment: Buy Disclosure: Held

16 Upvote

2 Great analysis

Top Stories

The Rising Tide: How institutional adoption is shaping the future of crypto

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

NRX

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

IPH

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

There are more pages in this discussion • 12,841 more messages in this thread...

First 7348 Last

Add IHL (ASX) to my watchlist

	Timeline	Expected Events	Share Price Projection
1	Dec 2021	1.IHL 42X – Complete Phase 2 Trials – Submit FDA Pre-IND 2.IHL – 216A - Complete Phase 2 Trials – Submit FDA Pre-IND 3.IHL 675A – Complete Phase 1 Trials (IBD, ILD, RA) 4.PSI – GAD (Commence Phase 2A trials)	75 – 99 Cents
2	March 2022	1.IHL 675A - Submit FDA Pre-IND	$0.8 to $1.2
3	September 2022	1.IND submission for IHL 42X 2.IND submission for IHL 216A 3.Submission of FDA Pre-IND for Phase 2 trials of IHL 675 A )(IBD, ILD) 4.IND Submission for PSI – General Anxiety Disorder	$1 - $1.5
4	June 2023	1.IND submission for IHL 675 (RA)	$1.2 - $1.75

General discussion, page-7348

Top Stories

The Rising Tide: How institutional adoption is shaping the future of crypto

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

Featured News